Consultation: Product Information as a package insert - consumer administered injectables
Privacy notice and consent to publish
The Therapeutic Goods Administration (TGA) invites you to share your views on the Product Information (PI) as a package insert for injectables administered by consumers (patients or carers).
Your personal information is protected by law, including the Privacy Act 1988 (Privacy Act) and the Australian Privacy Principles, and is being collected by the TGA, via Citizen Space, for the purposes of conducting this consultation.
The TGA handles submission in accordance with our information policy and publishes submissions at our discretion. If you consent, the TGA may publish part or all of your submission on the Department’s website. Before publication, personally identifying information will be removed. Please note responses may also be moderated to remove content that is inappropriate/offensive, or contains sensitive information. Submissions which contain personal information will be handled in accordance with our privacy policy.
You should not include information in your submission about another individual who is identified, or reasonably identifiable. If you need to include information about another individual in your submission, you will need to inform that individual of the contents of this notice, and obtain their consent to the Department collecting their personal information.